Glenmark Pharmaceuticals Ltd. (Glenmark) a research-led, global pharmaceutical company, launched TEVIMBRA® (tislelizumab) in India following the approval by Central Drugs Standard Control Organization (CDSCO). TEVIMBRA is a uniquely designed anti-PD-1 monoclonal antibody developed by BeiGene (now BeOne Medicines), a global oncology leader committed to delivering advanced treatments for cancer patients worldwide. It is indicated for the […]
Early diagnosis saves Bengaluru man’s life with lung cancer through advanced procedures
When 52-year-old Rahul (name altered), a non-smoker and fitness enthusiast, started experiencing a persistent cough, he initially thought it was a seasonal allergy. But after months, the cough persisted, and he noticed breathlessness while climbing stairs. A CT scan showed a localised lesion in the right upper lobe of his lung, raising concerns that something […]